Recent News

• 09.09.2025 - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
• 09.09.2025 - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
• 09.09.2025 - First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
• 09.08.2025 - Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
• 08.14.2025 - Q2 2025 Lifeward, Inc. Earnings Conference Call
• 08.14.2025 - Lifeward Ltd. Reports Second Quarter 2025 Financial Results
• 08.13.2025 - Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

Recent Filings

• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 08.25.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 08.25.2025 - S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments
• 08.14.2025 - EX-99.1 EX-99.1
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.14.2025 - 8-K Current report